Literature DB >> 24257215

Neurologic complications of metronidazole.

Justyna R Sarna, Sarah Furtado, A Keith W Brownell.   

Abstract

Metronidazole (Flagyl®) is an antimicrobial agent commonly used in clinical practice. Although it is generally well tolerated with minimal side effects, there are a host of still under-recognized neurologic complications of metronidazole treatment. The following review is aimed at summarizing current literature pertaining to metronidazole-induced neurotoxicity including clinical syndromes, neuroradiological findings, prognosis and proposed pathophysiology. Recognition of the neurotoxic effects of metronidazole is critical as prompt discontinuation is generally associated with full clinical recovery and radiological resolution. Complications neurologiques du métronidazole. Le métronidazole (Flagyl®) est un agent antimicrobien utilisé couramment en pratique clinique. Bien qu'il soit généralement bien toléré et que ses effets secondaires soient minimes, il existe une myriade de complications neurologiques du traitement par le métronidazole qui ne sont pas toujours reconnues. Le but de cette revue constitue un sommaire de la littérature actuelle concernant la neurotoxicité induite par le métronidazole dont les syndromes cliniques, les constatations neuroradiologiques, le pronostic et l'hypothèse physiopathologique expliquant cette neurotoxicité. Il est important d'identifier ces effets neurotoxiques du métronidazole étant donné que l'arrět immédiat du traitement est généralement associé à une guérison clinique complète et à la disparition des signes radiologiques.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257215     DOI: 10.1017/s0317167100015870

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  8 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Defining metronidazole-induced encephalopathy.

Authors:  Akira Kuriyama; Jeffrey L Jackson
Journal:  J Neurol       Date:  2019-03-12       Impact factor: 4.849

3.  Reversible cerebellar neurotoxicity induced by metronidazole.

Authors:  Ariel Lefkowitz; Steven Shadowitz
Journal:  CMAJ       Date:  2018-08-13       Impact factor: 8.262

4.  Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Authors:  Estelle Guiard; Bénédicte Lelievre; Magali Rouyer; Frank Zerbib; Bertrand Diquet; Francis Mégraud; François Tison; Emmanuelle Bignon; Régis Lassalle; Cécile Droz-Perroteau; Nicholas Moore; Patrick Blin
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

5.  Bacteriology of aspiration pneumonia in patients with acute coma.

Authors:  Enise Lauterbach; Frederik Voss; Roland Gerigk; Michael Lauterbach
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

6.  Metronidazole-associated Neurologic Events: A Nested Case-control Study.

Authors:  Nick Daneman; Yi Cheng; Tara Gomes; Jun Guan; Muhammad M Mamdani; Farah E Saxena; David N Juurlink
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

Review 7.  Role of antibiotics for treatment of inflammatory bowel disease.

Authors:  Orna Nitzan; Mazen Elias; Avi Peretz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  Management of Primary and Recurrent Clostridium difficile Infection: An Update.

Authors:  Jocelyn Chai; Christine H Lee
Journal:  Antibiotics (Basel)       Date:  2018-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.